LONG-TERM DOPAMINERGIC THERAPY OF PARKINSON DISEASE
The use of dopaminergic tools, particularly levodopa and dopamine receptors agonists (DRA), for many years allowed to effectively control the major motor symptoms of Parkinson disease, supporting mobility and daily activity, and eventually increasing the survivability of patients. However, a few yea...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
Remedium Group LLC
2017-05-01
|
| Series: | Медицинский совет |
| Subjects: | |
| Online Access: | https://www.med-sovet.pro/jour/article/view/1871 |